Los Angeles Capital Management LLC Sells 101,807 Shares of CME Group Inc. (NASDAQ:CME)

Los Angeles Capital Management LLC reduced its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 52.8% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 91,182 shares of the financial services provider's stock after selling 101,807 shares during the quarter. Los Angeles Capital Management LLC's holdings in CME Group were worth $24,190,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the business. SeaCrest Wealth Management LLC lifted its position in shares of CME Group by 3.0% during the first quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock worth $366,000 after acquiring an additional 40 shares in the last quarter. New Age Alpha Advisors LLC raised its position in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 43 shares in the last quarter. OneAscent Financial Services LLC raised its position in CME Group by 4.0% during the first quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider's stock valued at $293,000 after purchasing an additional 43 shares in the last quarter. Ballentine Partners LLC raised its position in CME Group by 0.8% during the first quarter. Ballentine Partners LLC now owns 5,828 shares of the financial services provider's stock valued at $1,546,000 after purchasing an additional 45 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC grew its stake in shares of CME Group by 3.6% during the first quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock valued at $356,000 after buying an additional 47 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.

Insider Activity at CME Group

In other news, Director William R. Shepard bought 256 shares of the stock in a transaction dated Wednesday, June 25th. The shares were acquired at an average price of $270.53 per share, with a total value of $69,255.68. Following the completion of the acquisition, the director directly owned 258,196 shares in the company, valued at approximately $69,849,763.88. The trade was a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 390 shares of the firm's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $277.50, for a total transaction of $108,225.00. Following the completion of the sale, the general counsel owned 6,708 shares of the company's stock, valued at $1,861,470. This trade represents a 5.49% decrease in their position. The disclosure for this sale can be found here. Insiders sold 13,400 shares of company stock worth $3,680,610 over the last 90 days. 0.30% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

CME has been the topic of a number of analyst reports. Royal Bank Of Canada reissued a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Morgan Stanley upped their target price on shares of CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a report on Thursday, April 24th. UBS Group upped their target price on shares of CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a report on Friday, April 25th. Finally, Oppenheimer increased their price objective on shares of CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, CME Group presently has a consensus rating of "Hold" and an average price target of $261.80.

CME Group Price Performance

Shares of CME Group stock traded down $0.36 during trading hours on Tuesday, reaching $274.64. The stock had a trading volume of 2,682,922 shares, compared to its average volume of 2,185,026. The stock's 50 day moving average is $275.89 and its 200 day moving average is $261.04. The firm has a market capitalization of $98.97 billion, a PE ratio of 27.63, a PEG ratio of 4.81 and a beta of 0.44. CME Group Inc. has a twelve month low of $193.25 and a twelve month high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The company had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter in the prior year, the company earned $2.50 EPS. CME Group's revenue was up 10.4% compared to the same quarter last year. Equities analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were issued a dividend of $1.25 per share. The ex-dividend date was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.82%. CME Group's dividend payout ratio (DPR) is presently 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.